Arterial phase carotid and vertebral artery imaging in 3D contrast-enhanced MR angiography by combining fluoroscopic triggering with an elliptical centric acquisition order.
Arterial-phase three-dimensional (3D) contrast-enhanced MR angiograms of the carotid and vertebral arteries from their origins through the carotid bifurcations were obtained in 20 patients using acquisition times over 30 sec by using an MR fluoroscopy-triggered pulse sequence with elliptical centric view order. The typical pixel size was 0.8 mm (x) x 1.6 mm (y) x 1.5 mm (z), and 32-48 coronal slices were acquired. The fluoroscopic monitoring of bolus arrival was effective in 18 of the 20 cases; two failures were attributed directly to a poor choice of RF coil. To exploit peak arterial-to-venous contrast, the central 3D views were acquired first in the most compact time period possible for the given TR. For the 18 successfully triggered cases, arterial-phase 3D images were obtained with excellent venous suppression as demonstrated by an average internal jugular vein to common carotid signal enhancement ratio of only 0.05 +/- 0.04.
Wilman
A H
AH
Department of Diagnostic Radiology, Mayo Clinic, Rochester, Minnesota 55905, USA.
Riederer
S J
SJ
Huston
J
J
Wald
J T
JT
Debbins
J P
JP
D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D002339:Carotid Arteries / Q000000981:diagnostic imaging / Q000473:pathology*; D003287:Contrast Media; D005260:Female; D005471:Fluoroscopy / Q000295:instrumentation / Q000379:methods*; D005682:Gadolinium; D006571:Heterocyclic Compounds; D006801:Humans; D018810:Magnetic Resonance Angiography / Q000295:instrumentation / Q000379:methods*; D008297:Male; D008875:Middle Aged; D009942:Organometallic Compounds; D011856:Radiographic Image Enhancement / Q000379:methods*; D012680:Sensitivity and Specificity; D014652:Vascular Diseases / Q000175:diagnosis*; D014711:Vertebral Artery / Q000000981:diagnostic imaging / Q000473:pathology*
D003287:Contrast Media; D006571:Heterocyclic Compounds; D009942:Organometallic Compounds; C062402:gadoteridol; D005682:Gadolinium